Skip to menu Skip to content Skip to footer

2024

Journal Article

The genomic epidemiology of clinical Burkholderia pseudomallei isolates in North Queensland, Australia

Gassiep, Ian, Chatfield, Mark D., Permana, Budi, Burnard, Delaney, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Mayer-Coverdale, Johanna, Norton, Robert E. and Harris, Patrick N. A. (2024). The genomic epidemiology of clinical Burkholderia pseudomallei isolates in North Queensland, Australia. Pathogens, 13 (7) 584, 584. doi: 10.3390/pathogens13070584

The genomic epidemiology of clinical Burkholderia pseudomallei isolates in North Queensland, Australia

2024

Journal Article

Patient outcome quality indicators for older persons in acute care: original development data using interRAI AC-CGA

Martin-Khan, Melinda G., Gray, Leonard C., Brand, Caroline, Wright, Olivia, Pachana, Nancy A., Byrne, Gerard J., Chatfield, Mark D., Jones, Richard, Morris, John, Travers, Catherine, Tropea, Joanne, Xiong, Beibei, Research Collaborative for Quality Care: Acute Care Panel and Research Collaborative for Quality Care: Dementia Care Panel (2024). Patient outcome quality indicators for older persons in acute care: original development data using interRAI AC-CGA. BMC Geriatrics, 24 (1) 527, 1-13. doi: 10.1186/s12877-024-04980-9

Patient outcome quality indicators for older persons in acute care: original development data using interRAI AC-CGA

2024

Journal Article

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

Leach, Amanda Jane, Wilson, Nicole, Arrowsmith, Beth, Beissbarth, Jemima, Mulholland, Kim, Santosham, Mathuram, Torzillo, Paul John, McIntyre, Peter, Smith-Vaughan, Heidi, Skull, Sue A., Oguoma, Victor M., Chatfield, Mark D., Lehmann, Deborah, Brennan-Jones, Christopher G., Binks, Michael J., Licciardi, Paul V., Andrews, Ross M., Snelling, Tom, Krause, Vicki, Carapetis, Jonathan, Chang, Anne B. and Morris, Peter Stanley (2024). Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS Medicine, 21 (6) e1004375, 1-15. doi: 10.1371/journal.pmed.1004375

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

2024

Conference Publication

Technology assisted and remotely delivered anxiety psychotherapy intervention for people living with dementia and their care partners: Tech-CBT project

Au, T., Beattie, E., Bennett, S., Brooks, D., Broome, A., Byrne, G., Chatfield, M., Comans, T., Dissanayaka, N., Guy, R., Keramat, S.A., King, T., Lehn, A., Liddle, J., Mitchell, L., Oram, J., O’Sullivan, J., Pacas Fronza, G., Pachana, N., Pietsch, A., Tan, J., Welsh, K. and Worthy, P. (2024). Technology assisted and remotely delivered anxiety psychotherapy intervention for people living with dementia and their care partners: Tech-CBT project. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024.

Technology assisted and remotely delivered anxiety psychotherapy intervention for people living with dementia and their care partners: Tech-CBT project

2024

Conference Publication

Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project

Au, T., Bailey, D., Beattie, E., Brooks, D., Broome, A., Byrne, G., Chatfield, M., Dissanayaka, N., Keramat, S.A., Lehn, A., Liddle, J., Marsh, R., Mitchell, L., Naismith, S., Nestor, S., O’Sullivan, J., Pachana, N., Pourzinal, D., Robertson, S., Shrubsole, K., Sivakumaran, K., Spooner, D., Tinson, H., Verreynne, M.L., Worthy, P. and Yang, J. (2024). Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024.

Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project

2024

Journal Article

The effects of vibrating shoe insoles on standing balance, walking, and ankle-foot muscle activity in adults with diabetic peripheral neuropathy

Hatton, Anna L., Chatfield, Mark D., Cattagni, Thomas and Vicenzino, Bill (2024). The effects of vibrating shoe insoles on standing balance, walking, and ankle-foot muscle activity in adults with diabetic peripheral neuropathy. Gait and Posture, 111, 8-13. doi: 10.1016/j.gaitpost.2024.04.008

The effects of vibrating shoe insoles on standing balance, walking, and ankle-foot muscle activity in adults with diabetic peripheral neuropathy

2024

Conference Publication

Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.

Burgess, A., Chatfield, M., Jackman, M., Thorley, M., Reedman, S., Patel, M., Boyd, R.N. and Sakzewski, L. (2024). Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.. European Academy of Childhood Disabilty, Bruges, Belgium, 29 May-1 June 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.

2024

Journal Article

Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study

Collaro, Andrew J., Foong, Rachel, Chang, Anne B., Marchant, Julie M., Blake, Tamara L., Cole, Johanna F., Pearson, Glenn, Hii, Rebecca, Brown, Henry, Chatfield, Mark D., Hall, Graham and McElrea, Margaret S. (2024). Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study. Medical Journal of Australia, 220 (10), 523-529. doi: 10.5694/mja2.52306

Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study

2024

Journal Article

Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial

Chang, Anne B., Yerkovich, Stephanie T., Baines, Katherine J., Burr, Lucy, Champion, Anita, Chatfield, Mark D., Eg, Kah P, Goyal, Vikas, Marsh, Robyn L, McCallum, Gabrielle B, McElrea, Margaret, McPhail, Steven, Morgan, Lucy C, Morris, Peter S, Nathan, Anne M, O’Farrell, Hannah, Sanchez, Marion O, Parsons, Marianne, Schultz, André, Torzillo, Paul J, West, Nicholas P, Versteegh, Lesley, Marchant, Julie M and Grimwood, Keith (2024). Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open Respiratory Research, 11 (1) e002216, e002216. doi: 10.1136/bmjresp-2023-002216

Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial

2024

Journal Article

Combination of antistaphylococcal β-lactam with standard therapy compared to standard therapy alone for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking approach

Petersiel, Neta, Davis, Joshua S., Meagher, Niamh, Price, David J., Tong, Steven Y. C., Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA2) Study Group, Lye, David C., Yahav, Dafna, Sud, Archana, Robinson, J. Owen, Nelson, Jane, Archuleta, Sophia, Roberts, Matthew A., Cass, Alan, Paterson, David L., Foo, Hong, Paul, Mical, Guy, Stephen D., Tramontana, Adrian R., Walls, Genevieve B., McBride, Stephen, Bak, Narin, Ghosh, Niladri, Rogers, Benjamin A., Ralph, Anna P., Davies, Jane, Ferguson, Patricia E., Dotel, Ravindra, McKew, Genevieve L. ... Sullivan, Matthew V. N. O. (2024). Combination of antistaphylococcal β-lactam with standard therapy compared to standard therapy alone for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking approach. Open Forum Infectious Diseases, 11 (5) ofae181. doi: 10.1093/ofid/ofae181

Combination of antistaphylococcal β-lactam with standard therapy compared to standard therapy alone for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking approach

2024

Journal Article

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Graves, Bianca, Sinclair, Holly, Brischetto, Anna, Lim, Karen, Parkes-Smith, Jill, Eustace, Matthew, Davidson, Natalie, Tabah, Alexis, Stewart, Adam, Chatfield, Mark D., Harris, Patrick N.A. and Paterson, David L. (2024). Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications. Clinical Infectious Diseases, 78 (2), 283-291. doi: 10.1093/cid/ciad663

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

2024

Journal Article

Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial

Hardy, Melissa, Harris, Patrick N. A., Paterson, David L., Chatfield, Mark D., Mo, Yin, for the MERINO trial investigators, Tambyah, Paul A., Lye, David C., Lee, Tau H., Yilmaz, Mesut, Alenazi, Thamer H., Arabi, Yaseen, Falcone, Marco, Bassetti, Matteo, Righi, Elda, Rogers, Benjamin A., Kanj, Souha, Bhally, Hasan, Iredell, Jon, Mendelson, Marc, Boyles, Tom H., Looke, David, Miyakis, Spiros, Walls, Genevieve, Al Khamis, Mohammed, Zikri, Ahmed, Crowe, Amy, Ingram, Paul, Daneman, Nick ... Peleg, Anton Y. (2024). Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial. Clinical Infectious Diseases, 78 (6), 1482-1489. doi: 10.1093/cid/ciae050

Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial

2024

Conference Publication

The molecular epidemiology of Burkholderia pseudomallei in North Queensland

Gassiep, Ian, Burnard, Delaney, Permana, Budi, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Chatfield, Mark D., Ling, Weiping, Mayer-Coverdale, Johanna, Norton, Robert and Harris, Patrick N.A. (2024). The molecular epidemiology of Burkholderia pseudomallei in North Queensland. Pathology Update 2024, Adelaide, VIC, Australia, 1 - 3 March 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2023.12.133

The molecular epidemiology of Burkholderia pseudomallei in North Queensland

2024

Conference Publication

Nice log (and log-like) scaled axes

Chatfield, Mark (2024). Nice log (and log-like) scaled axes. 11th Oceania Stata Conference, Virtual, 1 February 2024. https://sugm.net.au/2024.html:

Nice log (and log-like) scaled axes

2023

Journal Article

Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study

Peri, Anna Maria, Rafiei, Nastaran, O’Callaghan, Kevin, Brischetto, Anna, Graves, Bianca, Sinclair, Holly, Eustace, Matthew, Lim, Karen, Parkes-Smith, Jill, Stewart, Adam, Davidson, Natalie, Tabah, Alexis, Bergh, Haakon, Chatfield, Mark D., Harris, Patrick N. A. and Paterson, David L. (2023). Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study. Infectious Diseases, 56 (4), 268-276. doi: 10.1080/23744235.2023.2294122

Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study

2023

Journal Article

A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease

King, Shannon J., Reid, Natasha, Brown, Sarah J., Brodie, Lucinda J., Sia, Aaron D. H., Chatfield, Mark D., Francis, Ross S., Peel, Nancye M., Gordon, Emily H. and Hubbard, Ruth E. (2023). A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease. BMC Geriatrics, 23 (1) 664, 664. doi: 10.1186/s12877-023-04365-4

A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease

2023

Journal Article

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

Dissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

2023

Journal Article

Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: findings from two randomised controlled trials of combined pneumococcal conjugate vaccines

Leach, A. J., Wilson, N., Arrowsmith, B., Beissbarth, J., Mulholland, E. K., Santosham, M., Torzillo, P. J., McIntyre, P., Smith-Vaughan, H., Skull, S. A., Oguoma, V. M., Chatfield, M., Lehmann, D., Binks, M. J., Licciardi, P. V., Andrews, R., Snelling, T., Krause, V., Carapetis, J., Chang, A. B. and Morris, P. S. (2023). Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: findings from two randomised controlled trials of combined pneumococcal conjugate vaccines. International Journal of Pediatric Otorhinolaryngology, 175 111776, 111776. doi: 10.1016/j.ijporl.2023.111776

Otitis media at 6-monthly assessments of Australian First Nations children between ages 12–36 months: findings from two randomised controlled trials of combined pneumococcal conjugate vaccines

2023

Journal Article

Vertebral CT attenuation outperforms standard clinical fracture risk prediction tools in detecting osteoporotic disease in lung cancer screening participants

Patel, Nikita, Dahl, Katrina, O'Rourke, Rachael, Williamson, Anne, Chatfield, Mark D., Fong, Kwun M., Yang, Ian A. and Marshall, Henry M. (2023). Vertebral CT attenuation outperforms standard clinical fracture risk prediction tools in detecting osteoporotic disease in lung cancer screening participants. The British Journal of Radiology, 96 (1151) 20220992, 1-9. doi: 10.1259/bjr.20220992

Vertebral CT attenuation outperforms standard clinical fracture risk prediction tools in detecting osteoporotic disease in lung cancer screening participants

2023

Journal Article

Melioidosis Queensland: an analysis of clinical outcomes and genomic factors

Gassiep, Ian, Burnard, Delaney, Permana, Budi, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Chatfield, Mark D., Ling, Weiping, Norton, Robert and Harris, Patrick N. A. (2023). Melioidosis Queensland: an analysis of clinical outcomes and genomic factors. PLoS Neglected Tropical Diseases, 17 (10) e0011697, 1-13. doi: 10.1371/journal.pntd.0011697

Melioidosis Queensland: an analysis of clinical outcomes and genomic factors